HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Behavioral studies with anxiolytic drugs. II. Interactions of zopiclone with ethyl-beta-carboline-3-carboxylate and Ro 15-1788 in squirrel monkeys.

Abstract
The effects of zopiclone (0.1-100 mg/kg) were studied alone and in combination with the benzodiazepine receptor antagonist Ro 15-1788 and the inverse agonist ethyl-beta-carboline-3-carboxylate (beta-CCE). Under one procedure, food-maintained responding of squirrel monkeys was punished during one component of a multiple schedule. Each 30th response during both components produced food and, during the punishment component, also produced electric shock. Intermediate doses of zopiclone (0.3-30 mg/kg) did not affect or decreased unpunished responding and produced large increases in punished responding; higher zopiclone doses decreased responding under both conditions. beta-CCE (0.1-3 mg/kg) reversed both the rate-increasing and the rate-decreasing effects of zopiclone under each condition, producing a dose-dependent shift to the right of the zopiclone dose-effect curves. All doses of beta-CCE higher than 0.1 mg/kg decreased responding when given alone. Ro 15-1788 (0.1 or 1 mg/kg), which had no effect on punished or unpunished responding, reversed both the rate-increasing and the rate-decreasing effects of zopiclone. Under a second procedure, zopiclone increased responding of squirrel monkeys maintained by food under a 5-min fixed-interval schedule at doses that did not affect or decreased responding comparably maintained in an alternate component by response-produced electric shock. These effects were also reversed by both Ro 15-1788 and beta-CCE. When administered alone, beta-CCE produced effects opposite those of zopiclone and the benzodiazepines by decreasing responding maintained by food and increasing shock-maintained responding.(ABSTRACT TRUNCATED AT 250 WORDS)
AuthorsJ E Barrett, L S Brady, J A Stanley, R S Mansbach, J M Witkin
JournalThe Journal of pharmacology and experimental therapeutics (J Pharmacol Exp Ther) Vol. 236 Issue 2 Pg. 313-9 (Feb 1986) ISSN: 0022-3565 [Print] United States
PMID2868115 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Anti-Anxiety Agents
  • Azabicyclo Compounds
  • Benzodiazepinones
  • Carbolines
  • Piperazines
  • Receptors, GABA-A
  • zopiclone
  • Flumazenil
  • Chlordiazepoxide
  • beta-carboline-3-carboxylic acid ethyl ester
Topics
  • Animals
  • Anti-Anxiety Agents (administration & dosage, pharmacology)
  • Azabicyclo Compounds
  • Behavior, Animal (drug effects)
  • Benzodiazepinones (administration & dosage, pharmacology)
  • Carbolines (administration & dosage, pharmacology)
  • Chlordiazepoxide (pharmacology)
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Electroshock
  • Female
  • Flumazenil
  • Food
  • Male
  • Piperazines (administration & dosage, pharmacology)
  • Punishment
  • Receptors, GABA-A (drug effects)
  • Saimiri

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: